中国医药指南
中國醫藥指南
중국의약지남
Guide of China Medicine
2015年
28期
197-197,198
,共2页
输血%乙型肝炎两对半%献血者
輸血%乙型肝炎兩對半%獻血者
수혈%을형간염량대반%헌혈자
Blood transfusion%Liver two half-and-half%Blood donor
本文给出了1例临床输血前后乙型肝炎两对半结果的变化过程,输血是临床上一种重要的治疗疾病的手段,而献血者主要采用酶免疫法检测HBSAg和ALT,大量输血对患者的两对半结果有一定的影响。因此对有输血史的患者,临床医师和实验人员对传染性指标结果的解释应慎重,必要时可建议患者输血后1个月左右进行复查。
本文給齣瞭1例臨床輸血前後乙型肝炎兩對半結果的變化過程,輸血是臨床上一種重要的治療疾病的手段,而獻血者主要採用酶免疫法檢測HBSAg和ALT,大量輸血對患者的兩對半結果有一定的影響。因此對有輸血史的患者,臨床醫師和實驗人員對傳染性指標結果的解釋應慎重,必要時可建議患者輸血後1箇月左右進行複查。
본문급출료1례림상수혈전후을형간염량대반결과적변화과정,수혈시림상상일충중요적치료질병적수단,이헌혈자주요채용매면역법검측HBSAg화ALT,대량수혈대환자적량대반결과유일정적영향。인차대유수혈사적환자,림상의사화실험인원대전염성지표결과적해석응신중,필요시가건의환자수혈후1개월좌우진행복사。
This article presents the changing process of a Clinical case of second liver two half-and-half before and after the blood transfusion. Blood transfusion is an important means for the treatment of disease, the enzyme immunoassay method detection is mainly used to detect HBSAg and ALT, and there will be a certain inlfuence for patients who accept a large number of blood transfusions with two half-and-half results. For patients with a history of blood transfusion, the clinicians and researchers should be cautious to explain the results of infectious indicators, when it is necessary they can suggest patients to have a review after about 1 month of the blood transfusion.